PGXQP: Ann Moyer, M.D., Ph.D.
Ann Moyer, M.D., Ph.D., co-director of Mayo Clinic’s Molecular Technologies Laboratory, discusses Mayo Clinic Labs’ new focused pharmacogenomics panel. The test uses a real-time, PCR-based testing approach to perform geno- and phenotyping on 10 broadly ap
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:31)
Dr. Moyer, could you provide us a little bit about you and your background?
(01:18)
Would you mind sharing just a brief overview of the focus pharmacogenomics panel?
(03:32)
So coming back to that patient focus, which patients should have this testing? And when do you recommend to be performed?
(05:17)
Can you talk a little bit about what alternative test options are available and how they compare?
(07:58)
Can you comment on how the results from this test are used in patient care?
(11:55)
Any final thoughts you'd leave us with before we wrap up?